Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Egcg Cpd
2. Epigallo-catechin Gallate
3. Epigallocatechin Gallate
4. Epigallocatechin-3-gallate
5. Epigallocatechin-3-o-gallate
1. Egcg
2. 989-51-5
3. Epigallocatechin Gallate
4. Epigallocatechin 3-gallate
5. Tea Catechin
6. Epigallocatechin-3-gallate
7. (-)-epigallocatechin-3-o-gallate
8. Teavigo
9. Epigallocatechin-3-monogallate
10. (-)-epigallocatechin 3-gallate
11. (-)-epigallocatechol Gallate
12. Catechin Deriv.
13. Pf-egcg 90
14. Green Tea Extract
15. (2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate
16. Nvp-xaa 723
17. Bqm438ctel
18. (2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-chromen-3-yl 3,4,5-trihydroxybenzoate
19. [(2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-chromen-3-yl] 3,4,5-trihydroxybenzoate
20. Chebi:4806
21. Chembl297453
22. [(2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate
23. Dsstox_cid_567
24. Dsstox_rid_78830
25. Dsstox_gsid_29889
26. (2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
27. Benzoic Acid, 3,4,5-trihydroxy-, (2r,3r)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-3-yl Ester
28. Cas-989-51-5
29. Smr000449288
30. Ccris 3729
31. Sr-01000759328
32. Unii-bqm438ctel
33. L-epigallocatechin Gallate
34. Epigallocate
35. Epigalocatechin Gallate
36. (-)-egcg
37. Epigallocic Acid
38. Teatannin Ii
39. 2kdh
40. 3oob
41. 4awm
42. (-)-cis-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-1(2h)-benzopyran-3,5,7-triol 3-gallate
43. (-)-epigallocatechin 3-o-gallate
44. Kdh
45. Epigallocatechol, 3-gallate, (-)-
46. (-)-epigallocatechin Gallate (egcg)
47. Epigallocatcchin Gallate
48. Epigallocatechin-gallate
49. Epigallocatechol Gallate
50. Spectrum_000316
51. Specplus_000277
52. Spectrum2_000168
53. Spectrum3_000244
54. Spectrum4_001541
55. Spectrum5_000102
56. Galloyl-l-epigallocatechol
57. Egcg [who-dd]
58. Egcg [mi]
59. 3-o-galloylepigallocatechin
60. (-)-epigallocatechin Gallat
61. (-)-epigallocatehin Gallate
62. Schembl35258
63. Bspbio_001628
64. Epigallocatechin-gallate-(-)
65. Kbiogr_002002
66. Kbioss_000796
67. Spectrum210239
68. Cid_65064
69. Mls000758300
70. Mls001424000
71. Divk1c_006373
72. Spbio_000035
73. Epigallocatechin Monogallate, B
74. Gtpl7002
75. Megxp0_001166
76. Dtxsid1029889
77. Acon1_001054
78. Kbio1_001317
79. Kbio2_000796
80. Kbio2_003364
81. Kbio2_005932
82. Kbio3_001128
83. (-)-cis-3,3',4',5,5',7-hexahydroxy-flavane-3-gallate
84. Hms2051k21
85. Hms3649e08
86. 3-o-galloyl-(-)-epigallocatechin
87. Zinc3870412
88. Epigallocatechin 3-o-gallate
89. Tox21_201468
90. Tox21_303457
91. Bdbm50070942
92. Ccg-38378
93. Fr-109
94. Lmpk12030005
95. S2250
96. Akos015918182
97. Cs-1258
98. Db12116
99. Ds-9030
100. Epigallocatechin Gallate [inci]
101. Nc00078
102. Sdccgmls-0066550.p001
103. (-)-epigallocatechin Gallate, >=95%
104. (-)-epigallocatechin-3-gallate; Egcg
105. Ncgc00164319-01
106. Ncgc00164319-02
107. Ncgc00164319-03
108. Ncgc00164319-04
109. Ncgc00164319-06
110. Ncgc00257243-01
111. Ncgc00259019-01
112. (-)-epigallocatechin Gallate (85% (-)-epigallocatechin Gallate, 10% (-)-epigallocatechin, 5% (-)- Epicatechin Gallate)
113. Ac-34075
114. Bp-30205
115. Hy-13653
116. E0694
117. N1874
118. Sw197458-3
119. C09731
120. M01719
121. (-)-epigallocatechin Gallate, >=97.0% (hplc)
122. (-)-epigallocatechin Gallate, Analytical Standard
123. 989e515
124. A845931
125. Gallic Acid, 3-ester With Epigallocatechol, (-)-
126. Q393339
127. Sr-01000946601
128. (-)-epigallocatechin-3-o-gallate [usp-rs]
129. Q-100914
130. Sr-01000759328-5
131. Sr-01000759328-6
132. Sr-01000946601-1
133. Epigallocatechin-3-gallate 1000 Microg/ml In Acetonitrile
134. (-)-epigallocatechin Gallate, >=80% (hplc), From Green Tea
135. Epigallocatechin Gallate, Primary Pharmaceutical Reference Standard
136. (-)-epigallocatechin-3-o-gallate, United States Pharmacopeia (usp) Reference Standard
137. (2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl3,4,5-trihydroxybenzoate
138. [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate
139. Epigallocatechin Gallate, Pharmaceutical Secondary Standard; Certified Reference Material
140. (-)-cis-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2h)-benzopyran-3-yl Gallate
141. (-)-epigallocatechin Gallate (85% (-)-epigallocatechin Gallate, 10% (-)-epigallocatechin, 5% (-)-epicatechin Gallate)
142. (-)-epigallocatechin-3-o-gallate (egcg) (constituent Of Powdered Decaffeinated Green Tea Extract) [dsc]
143. (2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-chromen-3-yl-3,4,5-trihydroxybenzoate
144. 3,4,5-trihydroxybenzoic Acid (2r,3r)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-3-yl Ester
145. 3,4-dihydro-5,7-dihydroxy-2r-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-3r-yl-3,4,5-trihydroxybenzoate
146. Benzoic Acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-3-yl Ester, (2r-cis)-
147. Benzoic Acid, 3,4,5-trihydroxy-,(2r,3r)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-3-yl Ester
Molecular Weight | 458.4 g/mol |
---|---|
Molecular Formula | C22H18O11 |
XLogP3 | 1.2 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 4 |
Exact Mass | 458.08491139 g/mol |
Monoisotopic Mass | 458.08491139 g/mol |
Topological Polar Surface Area | 197 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 667 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anticarcinogenic Agents
Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
Antimutagenic Agents
Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. (See all compounds classified as Antimutagenic Agents.)
(-)-Epigallocatechin gallate has known human metabolites that include (-)-Epigallocatechin gallate, 3p-hydroxy-glucuronide and (-)-Epigallocatechin gallate, 4p-hydroxy-glucuronide.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?